Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: Contribution of caveolin-1 and PPARγ

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1636, Issue 2-3, 2004, Pages 196-204

  Guthmann, Florian ^a   Schachtrup, Christian ^b   Tölle, Angelika ^a   Wissel, Heide ^a   Binas, Bert ^c   Kondo, Hisatake ^d   Owada, Yuji ^d   Spener, Friedrich ^b   Rüstow, Bernd ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TEXAS A AND M UNIVERSITY   (United States)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Caveolin 1; double knockout; double ko; E ; E and H FABP; E H FABP; epidermal type; FABP; Fatty acid signalling; fatty acid binding protein; Fatty acid binding protein; H ; heart type; Knockout mouse; Peroxisome proliferator activated receptor; Surfactant

Indexed keywords

CAVEOLIN 1; CD36 ANTIGEN; DIPALMITOYLPHOSPHATIDYLCHOLINE; EPIDERMAL TYPE FATTY ACID BINDING PROTEIN; FATTY ACID; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; LIPID; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLCHOLINE; PIOGLITAZONE; PROTEIN; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; CELL ISOLATION; CELL LABELING; CONTROLLED STUDY; DEGRADATION; DIET; DRUG SELECTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC CODE; KNOCKOUT MOUSE; LUNG ALVEOLUS CELL TYPE 2; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYNTHESIS; TRANSPORT KINETICS; WILD TYPE;

ANIMALS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CAVEOLIN 1; CAVEOLINS; DNA PRIMERS; FATTY ACID-BINDING PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PALMITIC ACID; POLYMERASE CHAIN REACTION; PULMONARY ALVEOLI; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

MURINAE;

EID: 2942689824     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2003.10.015     Document Type: Review

References (51)

1. van Golde L.M., Batenburg J.J., Robertson B. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol. Rev. 68:1988;374-455
2. Maniscalco W.M., Finkelstein J.N., Parkhurst A.B. De novo fatty acid synthesis by freshly isolated alveolar type II epithelial cells. Biochim. Biophys. Acta. 751:1983;462-469
3. Buechler K.F., Rhoades R.A. De novo fatty acid synthesis in the perfused rat lung. Incorporation of palmitate into phospholipids. Biochim. Biophys. Acta. 665:1981;393-398
4. Batenburg J.J., Longmore W.J., van Golde L.M. The synthesis of phosphatidylcholine by adult rat lung alveolar type II epithelial cells in primary culture. Biochim. Biophys. Acta. 529:1978;160-170
5. Chander A., Fisher A.B. Choline-phosphate cytidyltransferase activity and phosphatidylcholine synthesis in rat granular pneumocytes are increased with exogenous fatty acids. Biochim. Biophys. Acta. 958:1988;343-351
6. Maniscalco W.M., Finkelstein J.N., Parkhurst A.B. Effects of exogenous fatty acids and inhibition of de novo fatty acid synthesis on disaturated phosphatidylcholine production by fetal lung cells and adult type II cells. Exp. Lung Res. 15:1989;473-489
7. Guthmann F., Hohoff C., Fechner H., Humbert P., Börchers T., Spener F., Rüstow B. Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. Eur. J. Biochem. 253:1998;430-436
8. Hanhoff T., Lücke C., Spener F. Insights into binding of fatty acids by fatty acid binding proteins. Mol. Cell.Biochem. 239:2003;45-54
9. Glatz J.F., Van-Nieuwenhoven F.A., Luiken J.J., Schaap F.G., van-der-Vusse G.J. Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism. Prostaglandins, Leukot. Essent. Fat. Acids. 57:1997;373-378
10. Wolfrum C., Buhlmann C., Rolf B., Börchers T., Spener F. Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim. Biophys. Acta. 1437:1999;194-201
11. Spitsberg V.L., Matitashvili E., Gorewit R.C. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur. J. Biochem. 230:1995;872-878
12. Glatz J.F., Storch J. Unravelling the significance of cellular fatty acid-binding proteins. Curr. Opin. Lipidol. 12:2001;267-274
13. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., Staels B., Auwerx J. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15:1996;5336-5348
14. Wolfrum C., Börchers T., Sacchettini J.C., Spener F. Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry. 39:2000;1469-1474
15. Wolfrum C., Borrmann C.M., Börchers T., Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2323-2328
16. Tan N.S., Shaw N.S., Vinckenbosch N., Liu P., Yasmin R., Desvergne B., Wahli W., Noy N. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell. Biol. 22:2002;5114-5127
17. Owada Y., Takano H., Yamanaka H., Kobayashi H., Sugitani Y., Tomioka Y., Suzuki I., Suzuki R., Terui T., Mizugaki M., Tagami H., Noda T., Kondo H. Altered water barrier function in epidermal-type fatty acid binding protein-deficient mice. J. Invest. Dermatol. 118:2002;430-435
18. Binas B., Danneberg H., McWhir J., Mullins L., Clark A.J. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 13:1999;805-812
19. Stremmel W., Pohl L., Ring A., Herrmann T. A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids. 36:2001;981-989
20. Dobbs L.G., Gonzalez R., Williams M.C. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 134:1986;141-145
21. Kolleck I., Wissel H., Guthmann F., Schlame M., Sinha P., Rüstow B. HDL-holoparticle uptake by alveolar type II cells: effect of vitamin E status. Am. J. Respir. Cell Mol. Biol. 27:2002;57-63
22. Guthmann F., Haupt R., Looman A.C., Spener F., Rüstow B. Fatty acid translocase/CD36 mediates the uptake of palmitate by type II pneumocytes. Am. J. Physiol. 277:1999;L191-L196
23. Richieri G.V., Anel A., Kleinfeld A.M. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry. 32:1993;7574-7580
24. Ryan A.J., McCoy D.M., Mathur S.N., Field F.J., Mallampalli R.K. Lipoprotein deprivation stimulates transcription of the CTP:phosphocholine cytidylyltransferase gene. J. Lipid Res. 41:2000;1268-1277
25. Rüstow B., Kunze D. The availability of endogenous and exogenous disaturated diacylglycerol for the diacylglycerol-consuming reactions in lung microsomes. Biochim. Biophys. Acta. 796:1984;359-363
26. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917
27. Mason R.J., Nellenbogen J., Clements J.A. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17:1976;281-284
28. Kolleck I., Schlame M., Fechner H., Looman A.C., Wissel H., Rüstow B. HDL is the major source of vitamin E for type II pneumocytes. Free Radic. Biol. Med. 27:1999;882-890
29. Witt W., Kolleck I., Rüstow B. Identification of high density lipoprotein-binding proteins, including a glycosyl phosphatidylinositol-anchored membrane dipeptidase, in rat lung and type II pneumocytes. Am. J. Respir. Cell Mol. Biol. 22:2000;739-746
30. Hihi A.K., Michalik L., Wahli W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59:2002;790-798
31. Storch J., Thumser A.E. The fatty acid transport function of fatty acid-binding proteins. Biochim. Biophys. Acta. 1486:2000;28-44
32. Veerkamp J.H., Van-Moerkerk-And H.T., Zimmerman A.W. Effect of fatty acid-binding proteins on intermembrane fatty acid transport studies on different types and mutant proteins. Eur. J. Biochem. 267:2000;5959-5966
33. Thumser A.E., Tsai J., Storch J. Collision-mediated transfer of long-chain fatty acids by neural tissue fatty acid-binding proteins (FABP): studies with fluorescent analogs. J. Mol. Neurosci. 16:2001;143-150
34. Liou H.L., Storch J. Role of surface lysine residues of adipocyte fatty acid-binding protein in fatty acid transfer to phospholipid vesicles. Biochemistry. 40:2001;6475-6485
35. Bordewick U., Heese M., Börchers T., Robenek H., Spener F. Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol. Chem. Hoppe-Seyler. 370:1989;229-238
36. van-der-Vusse G.J., Glatz J.F., Stam H.C., Reneman R.S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol. Rev. 72:1992;881-940
37. Kingma P.B., Bok D., Ong D.E. Bovine epidermal fatty acid-binding protein: determination of ligand specificity and cellular localization in retina and testis. Biochemistry. 37:1998;3250-3257
38. Pohl J., Ring A., Stremmel W. Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway. J. Lipid Res. 43:2002;1390-1399
39. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83:1995;803-812
40. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93:1998;229-240
41. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884
42. Camp H.S., Whitton A.L., Tafuri S.R. PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes. FEBS Lett. 447:1999;186-190
43. Ren D., Collingwood T.N., Rebar E.J., Wolffe A.P., Camp H.S. PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev. 16:2002;27-32
44. Fra A.M., Williamson E., Simons K., Parton R.G. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8655-8659
45. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 293:2001;2449-2452
46. Bundgaard M., Frokjaer-Jensen J., Crone C. Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface. Proc. Natl. Acad. Sci. U. S. A. 76:1979;6439-6442
47. Anderson R.G., Kamen B.A., Rothberg K.G., Lacey S.W. Potocytosis: sequestration and transport of small molecules by caveolae. Science. 255:1992;410-411
48. Newman G.R., Campbell L., von-Ruhland C., Jasani B., Gumbleton M. Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function. Cell Tissue Res. 295:1999;111-120
49. Kolleck I., Guthmann F., Ladhoff A.M., Tandon N.N., Schlame M., Rüstow B. Cellular cholesterol stimulates acute uptake of palmitate by redistribution of fatty acid translocase in type II pneumocytes. Biochemistry. 41:2002;6369-6375
50. Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y.H., Cook R.F., Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126:1994;111-126
51. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:2001;785-791